Epirus: Leerink Global Healthcare Conference (Epirus Biopharmaceuticals) - Mar 21, 2015 - Anticipated initiation of P3 trial for RA in Q4 2015/Q1 2016; Anticipated launch in multiple South East Asian markets throughout 2016; Anticipated regulatory submission in Indonesia, Mexico, Thailand, Korea, Argentina and Malaysia for RA in 2015
Anticipated launch non-US • Anticipated non-US regulatory • Anticipated trial initiation date • Biosimilar
|